FR3010188B1 - THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMS - Google Patents
THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMSInfo
- Publication number
- FR3010188B1 FR3010188B1 FR1358503A FR1358503A FR3010188B1 FR 3010188 B1 FR3010188 B1 FR 3010188B1 FR 1358503 A FR1358503 A FR 1358503A FR 1358503 A FR1358503 A FR 1358503A FR 3010188 B1 FR3010188 B1 FR 3010188B1
- Authority
- FR
- France
- Prior art keywords
- rhumatisms
- theragnostic
- treatment
- chronic inflammatory
- chronic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001684 chronic effect Effects 0.000 title 1
- 230000002757 inflammatory effect Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rehabilitation Therapy (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1358503A FR3010188B1 (en) | 2013-09-05 | 2013-09-05 | THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1358503A FR3010188B1 (en) | 2013-09-05 | 2013-09-05 | THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMS |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3010188A1 FR3010188A1 (en) | 2015-03-06 |
FR3010188B1 true FR3010188B1 (en) | 2017-11-24 |
Family
ID=49816952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1358503A Expired - Fee Related FR3010188B1 (en) | 2013-09-05 | 2013-09-05 | THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMS |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR3010188B1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9857372B1 (en) | 2016-10-17 | 2018-01-02 | Reliant Immune Diagnostics, LLC | Arbovirus indicative birth defect risk test |
US11693002B2 (en) | 2016-10-17 | 2023-07-04 | Reliant Immune Diagnostics, Inc. | System and method for variable function mobile application for providing medical test results using visual indicia to determine medical test function type |
US11579145B2 (en) * | 2016-10-17 | 2023-02-14 | Reliant Immune Diagnostics, Inc. | System and method for image analysis of medical test results |
US11651866B2 (en) | 2016-10-17 | 2023-05-16 | Reliant Immune Diagnostics, Inc. | System and method for real-time insurance quote in response to a self-diagnostic test |
US10902951B2 (en) | 2016-10-17 | 2021-01-26 | Reliant Immune Diagnostics, Inc. | System and method for machine learning application for providing medical test results using visual indicia |
US11802868B2 (en) | 2016-10-17 | 2023-10-31 | Reliant Immune Diagnostics, Inc. | System and method for variable function mobile application for providing medical test results |
US11107585B2 (en) | 2016-10-17 | 2021-08-31 | Reliant Immune Diagnostics, Inc | System and method for a digital consumer medical wallet and storehouse |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2012DN00767A (en) * | 2009-07-28 | 2015-06-26 | Janssen Biotech Inc | |
KR20140072014A (en) * | 2011-06-16 | 2014-06-12 | 카리스 라이프 사이언스 룩셈부르크 홀딩스, 에스.에이.알.엘. | Biomarker compositions and methods |
-
2013
- 2013-09-05 FR FR1358503A patent/FR3010188B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR3010188A1 (en) | 2015-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR3046933B1 (en) | NLRP3 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS | |
MA41449A (en) | POLYTHERAPIES FOR THE TREATMENT OF CANCERS | |
IL243976B (en) | Kdm1a inhibitors for the treatment of disease | |
MA39748A (en) | CENICRIVIROC FOR THE TREATMENT OF FIBROSIS | |
ZA201604110B (en) | New treatment of chronic ulcers | |
MA42459A (en) | NEW APPROACH TO CANCER TREATMENT BY IMMUNOMODULATION | |
MA45429A (en) | POLYTHERAPY FOR CANCER TREATMENT | |
FR3010188B1 (en) | THERAGNOSTIC PROCESS FOR THE TREATMENT OF CHRONIC INFLAMMATORY RHUMATISMS | |
MA41555A (en) | POLYTHERAPY FOR CANCER TREATMENT | |
MA41123A (en) | POLYTHERAPY FOR CANCER TREATMENT | |
FR20C1044I2 (en) | TRIAZINES FOR THE TREATMENT OF PROTOZOIC INFECTIONS | |
MA42999A (en) | POLYTHERAPY FOR THE TREATMENT OF MALIGNITIES | |
FR3010925B1 (en) | PROCESS FOR PROCESSING A PART | |
FR3003861B1 (en) | NOVEL PROCESS FOR THE PREPARATION OF POLYOLS-GLYCOSIDES | |
MA39927A (en) | GLYT1 INHIBITORS FOR THE TREATMENT OF BLOOD DISORDERS | |
FR3039368B1 (en) | COSMETIC TREATMENT PROCESS | |
MA46999A (en) | MODIFIED OLIGONUCLEOTIDES TO TREAT RENAL POLYKYSTOSIS | |
HK1221166A1 (en) | The treatment of inflammatory disorders | |
FR3015285B1 (en) | FORMULATION FOR THE TREATMENT OF HAIR | |
FR3015726B1 (en) | SECURE COMPARATIVE PROCESSING METHOD | |
FR3021230B1 (en) | PROCESS FOR PURIFYING METAL NANOWIRS | |
EP2941255A4 (en) | Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof | |
FR3002690B1 (en) | PROCESS FOR PROCESSING A MAGNETIC STRUCTURE | |
MA47474A (en) | RATIONAL POLYTHERAPY FOR CANCER TREATMENT | |
FR3011542B1 (en) | PROCESS FOR THE DEOXIDATION OF SILICON |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
TQ | Partial transmission of property |
Owner name: UNIVERSITE JOSEPH FOURIER - GRENOBLE 1, FR Effective date: 20180924 Owner name: SINNOVIAL, FR Effective date: 20180924 Owner name: CENTRE HOSPITALIER UNIVERSITAIRE GRENOBLE, FR Effective date: 20180924 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 9 |
|
TQ | Partial transmission of property |
Owner name: UNIVERSITE GRENOBLE ALPES, FR Effective date: 20230130 Owner name: SINNOVIAL, FR Effective date: 20230130 Owner name: CENTRE HOSPITALIER UNIVERSITAIRE GRENOBLE, FR Effective date: 20230130 |
|
ST | Notification of lapse |
Effective date: 20230505 |